CRESCENT BIOPHARMA, INC. Prepaid Expense, Noncurrent
CRESCENT BIOPHARMA, INC. (CBIO) had Prepaid Expense, Noncurrent of $192.27 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseNoncurrent · last filed 2025-02-13
- 2024-03-31: Prepaid Expense, Noncurrent $192.27K.
- 2023-12-31: Prepaid Expense, Noncurrent $603.74K.
- 2023-09-30: Prepaid Expense, Noncurrent $50.00K.
- 2023-06-30: Prepaid Expense, Noncurrent $50.00K.
| Period end | Prepaid Expense, Noncurrent |
|---|---|
| 2024-03-31 | $192.27K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $603.74K 10-K · filed 2025-02-13 |
| 2023-09-30 | $50.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $50.00K 10-Q · filed 2023-08-02 |
| 2023-03-31 | $50.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $50.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $807.80K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.22M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $2.22M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $1.56M 10-K · filed 2023-03-29 |
| 2021-09-30 | $1.56M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $1.56M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.56M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $1.56M 10-K · filed 2022-03-03 |
| 2020-09-30 | $1.56M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.56M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $1.56M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $1.56M 10-K · filed 2021-03-02 |
| 2019-09-30 | $1.56M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.56M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $1.56M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.71M 10-Q · filed 2018-11-02 |
| 2018-06-30 | $1.71M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $204.36K 10-Q · filed 2018-05-03 |
| 2017-12-31 | $204.36K 10-K · filed 2019-03-06 |
| 2017-09-30 | $759.53K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $759.53K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $759.53K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $759.53K 10-K · filed 2018-03-06 |
| 2016-09-30 | $759.53K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $696.53K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $696.53K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $696.53K 10-K · filed 2017-03-01 |
| 2015-09-30 | $696.53K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $696.53K 10-Q · filed 2015-08-06 |
| 2015-03-31 | $696.53K 10-Q · filed 2015-05-05 |
| 2014-12-31 | $696.53K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |